164 related articles for article (PubMed ID: 11188782)
1. The impact and management of anaemia in haematological malignancies.
Coiffier B
Med Oncol; 2000 Nov; 17 Suppl 1():S2-10. PubMed ID: 11188782
[TBL] [Abstract][Full Text] [Related]
2. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin.
Cazzola M
Med Oncol; 2000 Nov; 17 Suppl 1():S11-6. PubMed ID: 11188780
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
5. Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer.
Beguin Y
Med Oncol; 1998 Aug; 15 Suppl 1():S38-46. PubMed ID: 9785336
[TBL] [Abstract][Full Text] [Related]
6. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
7. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity.
Moyle G
AIDS Rev; 2002; 4(1):13-20. PubMed ID: 11998779
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and chronic lymphocytic leukemia.
Mauro FR; Gentile M; Foa R
Rev Clin Exp Hematol; 2002; Suppl 1():21-31. PubMed ID: 12735212
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human erythropoietin in the treatment of head and neck tumour anaemia.
Oettle H; Riess H; Raguse JD; Bier J; Gath HJ
Int J Oral Maxillofac Surg; 2001 Apr; 30(2):148-55. PubMed ID: 11405451
[TBL] [Abstract][Full Text] [Related]
10. [The effect of haemoglobin levels on prognosis and quality of life of patients with bronchial carcinoma].
Drings P; Wannenmacher M
Dtsch Med Wochenschr; 2005 Jun; 130(24):1507-11. PubMed ID: 15942841
[TBL] [Abstract][Full Text] [Related]
11. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
12. Epoetin beta therapy in patients with solid tumours.
Pronzato P; Jassem J; Mayordomo J
Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
[TBL] [Abstract][Full Text] [Related]
13. [Anemia in lymphoma].
de La Motte Rouge T; Schneider M
Bull Cancer; 2005 May; 92(5):429-31. PubMed ID: 15932805
[TBL] [Abstract][Full Text] [Related]
14. The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies.
Cornes P; Boiangiu I
Anticancer Res; 2007; 27(1B):513-22. PubMed ID: 17348435
[TBL] [Abstract][Full Text] [Related]
15. Anemia in multiple myeloma.
Ludwig H; Pohl G; Osterborg A
Clin Adv Hematol Oncol; 2004 Apr; 2(4):233-41. PubMed ID: 16163188
[TBL] [Abstract][Full Text] [Related]
16. Role of epoetin in the management of anaemia in patients with lung cancer.
Morère JF
Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
[TBL] [Abstract][Full Text] [Related]
17. Anaemia in cancer: pathophysiology and treatment.
Mercadante S; Gebbia V; Marrazzo A; Filosto S
Cancer Treat Rev; 2000 Aug; 26(4):303-11. PubMed ID: 10913385
[TBL] [Abstract][Full Text] [Related]
18. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
Mittelman M
Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
[TBL] [Abstract][Full Text] [Related]
19. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
